Program of vascular evaluation under uric acid control by xanthine oxidase inhibitor, febuxostat: multicenter, randomized controlled study

Trial Profile

Program of vascular evaluation under uric acid control by xanthine oxidase inhibitor, febuxostat: multicenter, randomized controlled study

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Jul 2016

At a glance

  • Drugs Febuxostat (Primary)
  • Indications Hyperuricaemia
  • Focus Pharmacodynamics
  • Acronyms PRIZE
  • Most Recent Events

    • 26 Jul 2016 Planned End Date changed from 31 Mar 2018 to 31 Jul 2018.
    • 26 Jul 2016 Status changed from recruiting to active, no longer recruiting.
    • 25 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top